NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Mannkind Corporation Share Price Chart

O H L

Mannkind Corporation Performance Overview

Days Range
$3.53Low
$3.58High

Markets Today

Previous Close$3.58
Open$3.58
Volume398,006
Day's Range$3.53 - $3.58
52W Range$2.23 - $6.51
Market Cap$1.14 B

Historical Performance

1M Returns-12.04
3M Returns-9.14
6M Returns+37.16
1Y Returns-36.19
5Y Returns-20.97
10Y Returns+2.73

Mannkind Corporation Fundamentals

Market Cap$1.14 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$348.97 M
ROE TTMN/A
EPS TTM$-0.14
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$58.83 M
Profit Margin1.68
Market Cap$1.14 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$348.97 M
ROE TTMN/A
EPS TTM$-0.14
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$58.83 M
Profit Margin1.68

Mannkind Corporation Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$78.35 M$76.53 M$82.13 M$111.95 M$90.17 M$109.37 M
Gross Profit +$60.84 M$55.96 M$61.93 M$82.28 M$72.70 M$79.83 M
Operating Income $24.80 M$10.66 M$18.78 M-$7.69 M-$2.98 M-$836.00 K
EBITDA $26.91 M$12.75 M$20.84 M-$1.66 M$3.40 M$5.56 M
Interest Expense -$10.63 M-$6.19 M-$7.33 M-$13.87 M-$12.43 M-$14.82 M
Depreciation $2.11 M$2.09 M$2.06 M$6.03 M$6.38 M$6.40 M
Income Before Tax $13.62 M$940.00 K$7.78 M-$20.93 M-$16.37 M-$19.14 M
Income Tax Expense $459.00 K$272.00 K-$204.00 K-$4.98 M$253.00 K-$106.00 K
Net Income +$13.16 M$668.00 K$7.99 M-$15.95 M-$16.62 M-$19.03 M
Net Profit Margin 16.79%0.87%9.72%-14.25%-18.43%-17.4%

Mannkind Corporation Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $3.04 M$3.06 M$3.07 M$3.08 M$3.09 M$3.10 M
Reserve & Surplus -$3.19 B-$3.19 B-$3.18 B-$3.20 B-$3.21 B-$3.23 B
Non-Current Liabilities $352.82 M$354.91 M$430.06 M$672.17 M$669.04 M$656.60 M
Current Liabilities $115.94 M$111.83 M$109.13 M$171.03 M$134.56 M$142.90 M
Total Liabilities $468.76 M$466.74 M$539.19 M$843.20 M$803.60 M$799.50 M
Fixed Assets $89.00 M$88.13 M$87.77 M$407.12 M$402.89 M$401.13 M
Current Assets $273.74 M$279.03 M$358.84 M$291.58 M$251.16 M$245.71 M
Total Assets $410.14 M$411.70 M$494.64 M$792.18 M$744.40 M$732.30 M

Mannkind Corporation Cash Flow

Dec 2025Dec 2025Mar 2026Mar 2026Jun 2026Jun 2026
Net Income -$15.95 M-$15.95 M-$16.62 M-$16.62 M-$19.03 M-$19.03 M
Operating Cash Flow -$7.96 M-$7.96 M-$5.37 M-$5.37 M-$18.37 M-$18.37 M
Investing Cash Flow -$291.96 M-$291.96 M$18.73 M$18.73 M$17.91 M$17.91 M
Financing Cash Flow $247.41 M$247.41 M-$35.41 M-$35.41 M$559.00 K$559.00 K
Change in Cash -$52.51 M-$52.51 M-$22.05 M-$22.05 M$97.00 K$97.00 K

Mannkind Corporation Return Calculator

The Mannkind Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$7,792
Invested Amount$10,000
Est. Returns$-2,208
Invest in USA Stock Today

About Mannkind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

FAQs

Mannkind Corporation (MNKD) share price as of September 18, 2026 is $3.53. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Mannkind Corporation (MNKD) Share by opening an international trading account with Angel One.
Purchasing Mannkind Corporation (MNKD) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Mannkind Corporation (MNKD) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Mannkind Corporation (MNKD) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Mannkind Corporation on September 18, 2026, is $1.14 B.
Mannkind Corporation operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Mannkind Corporation (MNKD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91